Cargando…

Diffuse Cutaneous Melanosis Associated with Malignant Melanoma

Detalles Bibliográficos
Autores principales:	Mangana, Joanna, Felderer, Lea, Cheng, Phil, French, Lars E., Dummer, Reinhard, Schad, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Dermatological Association; The Korean Society for Investigative Dermatology 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695441/ https://www.ncbi.nlm.nih.gov/pubmed/26719658 http://dx.doi.org/10.5021/ad.2015.27.6.780

Ejemplares similares

Diffuse cutaneous melanosis: rare complication of metastatic melanoma
por: do Amaral, Ana Cristina Vervloet, et al.
Publicado: (2017)

Diffuse Melanosis and Ascites due to Metastatic Malignant Melanoma
por: Sendagorta, Elena, et al.
Publicado: (2008)

Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis
por: Kraehenbuehl, Lukas, et al.
Publicado: (2023)

Neurocutaneous melanosis
por: Moreira, Bruno Lima, et al.
Publicado: (2016)

Cutavirus in Cutaneous Malignant Melanoma
por: Mollerup, Sarah, et al.
Publicado: (2017)

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)

Long-term pegylated interferon-α and its potential in the treatment of melanoma
por: Dummer, Reinhard, et al.
Publicado: (2009)

Atypical presentation of Becker's melanosis
por: Manoj, Jayasree, et al.
Publicado: (2011)

Primary malignant melanoma without melanosis of the colon
por: Yi, Nam Hee, et al.
Publicado: (2019)

Impact of Covid-19 on the management of patients with metastatic melanoma
por: Welti, Michèle, et al.
Publicado: (2022)

Addendum: Impact of Covid-19 on the management of patients with metastatic melanoma
por: Welti, Michèle, et al.
Publicado: (2023)

Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted Therapy
por: DIMITRIOU, Florentia, et al.
Publicado: (2020)

A new B-Raf inhibitor combo for advanced melanoma
por: Barysch, Marjam-Jeanette, et al.
Publicado: (2018)

Diffuse melanosis cutis related to dermal micrometastases as the first clinical symptom of distant metastatic malignant melanoma: Case report
por: Maj, Joanna, et al.
Publicado: (2017)

Tumoral Melanosis Arising on a Mycosis Fungoides Plaque
por: Demirdağ, Hatice Gamze, et al.
Publicado: (2018)

Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma
por: Fröhlich, Fabienne, et al.
Publicado: (2023)

Diffuse Melanosis in a Cow
por: Unvolette, Giuseppe
Publicado: (1893)

Melanoma patients with additional primary cancers: a single-center retrospective analysis
por: Dimitriou, Florentia, et al.
Publicado: (2019)

Reply to: The diagnostic accuracy of (18)F-FDG PET in cutaneous malignant melanoma
por: Delgado-Bolton, Roberto C., et al.
Publicado: (2010)

How I treat metastatic melanoma
por: Dummer, Reinhard, et al.
Publicado: (2019)

Toxicity of combined targeted therapy and concurrent radiotherapy in metastatic melanoma patients: a single-center retrospective analysis
por: Ziegler, Johanna S., et al.
Publicado: (2020)

Multiple primary malignancies and prolonged survival in a patient with widespread metastatic cutaneous melanoma
por: Rose, Anna M., et al.
Publicado: (2018)

Comment on ‘The burden of occupationally-related cutaneous malignant melanoma in Britain due to solar radiation'
por: Grant, William B
Publicado: (2017)

Review and comparison of body sites among patients with cutaneous malignant melanoma: an observational study
por: Wolinska, Anna, et al.
Publicado: (2023)

The Melanosis of Miners; or, Spurious Melanosis
por: Thomson, J. B.
Publicado: (1858)

Metastatic melanoma with diffuse melanosis histologically after stable response to talimogene laherparepvec therapy
por: Rizzo, Jason M., et al.
Publicado: (2018)

The role of cyclin D1 and Ki‐67 in the development and prognostication of thin melanoma
por: Kaufmann, Corina, et al.
Publicado: (2020)

A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma()
por: Krähenbühl, Lukas, et al.
Publicado: (2018)

Malignant Melanoma Arising from Esophageal Melanosis and Synchronous with Esophageal Squamous Cell Carcinoma
por: Ota, Yoshihiro, et al.
Publicado: (2023)

On Melanosis
Publicado: (1827)

On Melanosis
por: Cullen, William, et al.
Publicado: (1824)

A first case report of rare synchronous double cancers: malignant cutaneous melanoma and gastrointestinal stromal tumor
por: Zegarska, Barbara, et al.
Publicado: (2017)

Neurocutaneous Melanosis with Leptomeningeal Melanoma Involving Supratentorium and Infratentorium
por: Thomas, Solly, et al.
Publicado: (2018)

Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma
por: Bari, Omar, et al.
Publicado: (2017)

Peculiar Acral Melanosis after Cyclophosphamide Therapy in a Case of Primary Membranous Nephropathy: A Rare Presentation
por: Gharia, Shivangi, et al.
Publicado: (2020)

Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis
por: Dimitriou, Florentia, et al.
Publicado: (2021)

Lymphatic vessel density and prognosis in cutaneous melanoma
por: Straume, O, et al.
Publicado: (2004)

Reply to ‘Comment on ‘The burden of occupationally-related cutaneous malignant melanoma in Britain due to solar radiation'' – outdoor occupation may not be linked to increased risk of melanoma in Britain
por: Rushton, Lesley, et al.
Publicado: (2017)

Diffuse cutaneous leishmaniasis – A rare cutaneous presentation in an HIV-positive patient
por: Purohit, Hemang M., et al.
Publicado: (2012)

Neglected malignant neoplasms with cutaneous involvement
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ca8pae7774qddj5aaoq9j2g7nr